Eniola's strongest angle is to position GATE, TOPOLOGIX, and IMPRINT as *open-source scientific infrastructure tools for the European research internet* — not as outputs of her pharmacology research programme — and to propose a specific, scoped software deliverable within one of them. The highest-fit project is **TOPOLOGIX** (Apache/OSS-compatible TDA drug-protein interaction tool): persistent homology + bipartite simplicial complexes applied to hERG cardiotoxicity is genuinely novel open-source scientific software with no direct equivalent in the European open-source bioinformatics ecosystem, and it can be argued as serving EU pharmaceutical safety researchers and the open-data commons. The proposal should request a specific engineering milestone (e.g., 'publish TOPOLOGIX as a pip-installable Python library with documented API, CI test suite, and hERG benchmark dataset under CC BY 4.0') rather than funding Eniola's salary or research career, name two or three European research groups (e.g., a German or Austrian cheminformatics lab aligned with her MUG application) as target end-users or collaborators to satisfy the European dimension requirement, and lead with the open-source software deliverable in the abstract — CCT and IMPRINT can appear as ecosystem context but should not be the primary claim.